Evaluation of PD 154075, a tachykinin NK1 receptor antagonist, in a rat model of postoperative pain.

[1]  S. McCleary,et al.  Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. , 1997, The Journal of pharmacology and experimental therapeutics.

[2]  R. Naylor,et al.  The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret. , 1997, European journal of pharmacology.

[3]  S. Iyengar,et al.  LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. , 1997, The Journal of pharmacology and experimental therapeutics.

[4]  S. Boyce,et al.  Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils , 1996, PAIN.

[5]  R. Traub.  The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat , 1996, PAIN.

[6]  Timothy J. Brennan,et al.  Characterization of a rat model of incisional pain , 1996, Pain.

[7]  Q. Ma,et al.  Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. , 1995, The Journal of physiology.

[8]  M. Millan,et al.  Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent , 1995, Pain.

[9]  L. Urbán,et al.  Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters , 1994, Trends in Neurosciences.

[10]  S. Guard,et al.  Rational design of high affinity tachykinin NK1 receptor antagonists. , 1994, Bioorganic & medicinal chemistry.

[11]  T. Mizuguchi,et al.  Effects of intrathecal FK888, a novel dipeptide NK1 receptor antagonist, on the formalin test in the rat , 1993, Neuroscience Letters.

[12]  C. Woolf,et al.  Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. , 1993 .

[13]  M. Tohyama,et al.  Substance P receptor (NK-1) in the central nervous system: possible functions from a morphological aspect , 1993, Regulatory Peptides.

[14]  C. Maggi,et al.  Tachykinin receptors and tachykinin receptor antagonists. , 1993, Journal of autonomic pharmacology.

[15]  R. Elde,et al.  Biochemical characterization and regional quantification of μ, δ and κ opioid binding sites in rat spinal cord , 1991, Brain Research.

[16]  Clifford J. Woolf,et al.  The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states , 1991, Pain.

[17]  M. Randić,et al.  Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  R. Quirion,et al.  Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord , 1990, Brain Research.

[19]  A. Dickenson,et al.  Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn , 1986, Pain.

[20]  M. Moskowitz,et al.  Intraneuronal substance P contributes to the severity of experimental arthritis. , 1984, Science.

[21]  M. Kuhar,et al.  Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla , 1977, Brain Research.